Meisner Lara
CIK 0001883986
General Counsel and Secretary
Filings
11
Latest Feb 4, 2026
Issuers covered
2
Showing
11 of 11
Page 1
Track record
12 of 12 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 67% | -0.5% | +7.4% | +17.7% | -65.3% |
| 90 days | 12 | 75% | +8.1% | +16.3% | +39.9% | -61.3% |
| 180 days | 12 | 75% | +4.2% | +28.3% | +43.5% | -83.6% |
| 365 days | 9 | 78% | +26.0% | +50.6% | +55.4% | -56.2% |
Issuers
Companies where Meisner Lara has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\de | 6 | Jun 20, 2023 |
| BCAX | Bicara Therapeutics Inc. | 5 | Feb 4, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|